Autoimmune diseases are a group of more than 80 disorders in which one’s adaptive immune system attacks itself (Medline Plus, 2022). Autoimmune diseases can be localized or systemic and are the third most prominent group of disorders with varying etiologies (Angum et al., 2020; Desai & Brinton, 2019). Females are twice as likely to experience an autoimmune disorder when compared to males (Angum et al., 2020). This educational activity will focus on rheumatic autoimmune diseases (i.e., affecting the joints, muscles, or fibrous tissue) as this is the most prevalent autoimmune specialty. Other common autoimmune diseases and some rare disorders treated by other specialists will also be discussed. The goal of this course is to provide an introduction to autoimmune disease causes, treatment, and overall management.
Sponsored by Relias LLC, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to 1.00 total Category I continuing education contact hours.
District of Columbia Board of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Florida Board of Nursing (CEBroker Provider #50-290)
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Georgia Board of Nursing (CEBroker Provider #50-290)
South Carolina Board of Nursing (CEBroker Provider #50-290)
West Virginia Board of Registered Nursing (CEBroker Provider #50-290)
New Mexico Board of Nursing (CEBroker Provider #50-290)
Arkansas State Board Of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Kentucky Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.00 contact hours for participating in this course.
Mississippi Board of Nursing (CEBroker Provider #50-290)
North Dakota Board of Nursing (CEBroker Provider #50-290)
Relias LLC is an AOTA Approved Provider of professional development. Course approval ID# APP#0000004342. This Distance Learning-Independent is offered at 0.1000 CEUs, Intermediate, Foundational Knowledge. The assignment of AOTA CEUs does not imply endorsement of specific course content, products, or clinical procedures by AOTA.
Florida Board of Occupational Therapy (CEBroker Provider #50-290)
Alabama State Board Of Occupational Therapy (CEBroker Provider #50-290).
Arizona Board Of Occupational Therapy Examiners (CEBroker Provider #50-290).
Georgia State Board of Occupational Therapy (CEBroker Provider #50-290)
South Carolina Board Of Occupational Therapy (CEBroker Provider #50-290)
Louisiana State Board of Medical Examiners - Occupational Therapy (CEBroker Provider #50-290)
Mississippi State Department of Health- Occupational Therapy (CEBroker Provider #50-290)
Tennessee Board of Occupational Therapy (CEBroker Provider #50-290)
Section 1: Introduction
About This Course
Section 2: Autoimmune Disease Overview
The Current State of Autoimmune Diseases
Incidence & Prevalence
The Immune System: A Complex Orchestrated Pathophysiology
Causes of Autoimmune Diseases
Section 3: Common Rheumatic Autoimmune Diseases
Rheumatoid Arthritis (RA)
Systemic Lupus Erythematosus (SLE)
Primary Sjögren Syndrome (pSS)
Systemic Autoinflammatory Diseases (SAIDs)
Section 4: Autoimmune Diseases Treated by Other Specialists
Section 5: Rheumatic Autoimmune & SAID Treatment Classes
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Conventional Disease-Modifying Anti-Rheumatic Drugs (cDMARDs)
Other DMARDs: Immunosuppressive Agents
Section 6: Current Topics
COVID-19: Autoimmune & SAID Implications
Vaccine Safety & the Autoimmune Population
Section 7: Healthcare Implications & Care Management Recommendations
Section 8: Clinical Vignette
Section 9: Conclusion
Staff Writer: Laura Bell, BSN, RN, CCRN
Shalla is a SME/content writer for Relias. She completed her BSN and two undergraduate degrees with top honors from the University of Wisconsin-Madison. Shalla earned her dual MSN degrees from Johns Hopkins University with top honors. She also maintains her post-baccalaureate nurse educator certificate. Her tenure encompasses over 20 years of cross-functional leadership and direct clinical roles in healthcare, biopharma/biotech, government affairs, nonprofit patient advocacy & research organizations. Shalla is an accomplished writer, speaker, and published author with global experts. She also sits on scientific, advocacy, & legislative advisory boards. Her subject matter expertise is in rare, orphan, & complex diseases with sub-expertise in rheumatology, immunology, genetics, neurology, and several pediatric diseases.Disclosure: Shalla Newton, MSN, RN, NE-BC has no Relevant Financial or Non-Financial Relationship with ineligible companies to disclose.
Laura Bell, BSN, RN, CCRN is a SME writer for Relias with over 14 years of acute care experience in nursing. She began working in adult critical care at Wake Med Cary Hospital in 2011, obtained her CCRN certification in 2016, and served in the role of Rapid Response/Code Blue/Rounding RN for over 2 years. She continues to work as a staff nurse in the intensive care unit. Laura has a passion for education and excellence in nursing care. She has been involved in numerous special projects and educational activities to improve staff development, evidence-based clinical practice, and patient satisfaction. She continues to strive for excellence in education and clinical development as an acute care course writer. Disclosure: Laura Bell, BSN, RN, CCRN discloses the following potential conflict of interests/commercial interests: Relevant Financial Relationship with Relias LLC as a Salaried Employee All of the relationships listed for this individual have been mitigated.Relevant Non-Financial Relationship with No Entities Exists as a Contributor All of the relationships listed for this individual have been mitigated.
Access to over 1,450 courses! Access to 1,450+ courses for one low price.